Towada Products · New Delhi, India · Last updated:
Aprepitant is an NK1 receptor antagonist anti-emetic used for preventing nausea and vomiting caused by chemotherapy. Towada Products exports it from New Delhi, India, supplying Aprecap in the 125mg strength to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. Pricing is on enquiry.
Aprepitant is a neurokinin-1 (NK1) receptor antagonist. It blocks the action of substance P in the brain's vomiting centre, a pathway that is particularly important in the delayed nausea and vomiting that follows chemotherapy.
It is approved, in combination with a 5-HT3 antagonist and a corticosteroid, for preventing acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy, such as cisplatin-based regimens, and with moderately emetogenic chemotherapy, in adults and children. A separate low-strength capsule is approved in the United States for post-operative nausea and vomiting. The originator brand is Emend.
Oral aprepitant is commonly supplied as a three-day pack containing one 125mg capsule and two 80mg capsules; our catalog lists the 125mg presentation, so tell us whether you need single capsules or the pack. Granisetron and ondansetron, 5-HT3 antagonists used with aprepitant, are also in our catalog. Aprepitant interacts with some medicines through the liver enzyme CYP3A4, which prescribers check. The capsules are kept at room temperature, and oncology day-care units are the main buyers.
Aprepitant is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor. This page describes the medicine for trade buyers; it is not medical advice.
Every aprepitant product page on this site. "Listed for" is the use given in our catalog. Availability is confirmed when you enquire.
| Product | Composition | Listed for |
|---|---|---|
| Aprecap 125mg | Aprepitant (125mg) | Nausea and vomiting due to chemotherapy |
Export markets we serve: Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. See our export markets →
Tell us which documents your regulator or customs broker needs and we will confirm what applies to the product you are ordering.
Aprepitant is an NK1 receptor antagonist anti-emetic used for preventing nausea and vomiting caused by chemotherapy. It is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor.
Our catalog has 1 aprepitant product page in the 125mg strength, from 1 brand: Aprecap. The table on this page links to each product page; availability is confirmed when you enquire.
We ship from New Delhi by international courier or air cargo to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa, and have country pages for the Philippines, Russia, Kazakhstan, Uzbekistan, Iraq, Saudi Arabia and Brazil. Whether aprepitant can be imported, and by whom, is decided by the destination country's medicines regulator, so tell us the country and we will confirm what is possible. Every country we cover is listed on our export markets page.
Each shipment travels with a commercial invoice, a packing list and a courier or air waybill. We provide a Certificate of Analysis (CoA) for the batch and, where it is available for the product and the destination country requires it, a Certificate of Pharmaceutical Product (CoPP). A certificate of origin can be arranged on request.
Use the enquiry form on this page, WhatsApp +91 99995 62955 or email H.S.Gandhi@towadaproducts.in. Tell us the brand, strength, quantity and destination country, and we will reply with availability and a formal quotation.
This page is general information for trade buyers. It is not medical advice. Import rules differ by country and change over time; confirm the current requirements with your national medicines regulator before ordering.
Tell us the brand, strength, quantity and destination country. Pricing is confirmed in a formal quote. Prefer WhatsApp? Message +91 99995 62955.
Plain answers to the questions importers ask before ordering medicines from India.
